Books+ Search Results

Bioproperty, biomedicine, and deliberative governance : patents as discourse on life

Title
Bioproperty, biomedicine, and deliberative governance : patents as discourse on life / Katerina Sideri, the Open University, Greece.
ISBN
0754677389
0754694704
1322565791
1472403673
9780754677383
9780754694700
9781322565798
9781472403674
Publication
Farnham, Surrey, England ; Burlington, VT : Ashgate, [2014]
Copyright Notice Date
©2014
Physical Description
1 online resource (vi, 196 pages).
Local Notes
Access is available to the Yale community.
Access and use
Access restricted by licensing agreement.
Summary
Biomedical patents have been the subject of heated debate. Regulatory agencies such as the European Patent Office make small decisions with big implications, which escape scrutiny and revision, when they decide who has access to expensive diagnostic tests, whether human embryonic stem cells can be traded in markets, and under what circumstances human health is more important than animal welfare. Moreover, the administration of the Trade Related Aspects of Intellectual Property Rights by the World Trade Organization has raised considerable disquiet as it has arguably created grave health inequities. Those doubting the merits of the one size fits all approach ask whether priority should be given to serving the present needs of populations in dire need of medication or to promoting global innovation. The book looks in detail into the legal issues and ethical debates to ask the following three main questions: First, what are the ideas, goals, and broader ethical visions that underpin questions of governance and the legal reasoning employed by administrative agencies? Second, how can we democratize the decision making process of technocratic institutions such as the European Patent Office? Finally, how can we make the global intellectual property system more equitable? In answering these questions the book seeks to contribute to our understanding of the role and function of regulatory agencies in the regulation of the bioeconomy, explains the process of interpretation of legal norms, and proposes ways to rethink the reform of the patent system through the lens of legitimacy.-- Publisher desscription.
Variant and related titles
Taylor & Francis. EBA 2024-2025.
Other formats
Print version: Sideri, Katerina. Bioproperty, biomedicine, and deliberative governance. Farnham, Surrey, England ; Burlington, VT : Ashgate, [2014]
Format
Books / Online
Language
English
Added to Catalog
October 04, 2024
Series
Globalization and law.
Globalization and law
Bibliography
Includes bibliographical references (pages 181-192) and index.
Contents
Introduction : patents as discourse on life : the purposes of patents in the field of biotechnology and biomedical innovation
The European Patent Office, biotechnology, and ethics : revising ends of policy, and rethinking public deliberation
Neutral or practically wise regulator? genes, patents, and human health
Rethinking multilevel governance in the EU and the future of the EPO : from morality to ethics
Public bioethics, lay opinions, human need : from sex selection to enhancement
EPO and public bioethics : germ line interventions in human embryos, the problem of commodification and the question of incentives
TRIPs, access to medicines, and the global governance of patents, cultivating humanity and equity
Global health networks and discursive legitimacy
Some reflections on good patent governance
Conclusions : a discursive analysis of patents.
Subjects (Medical)
Biomedical Technology - legislation & jurisprudence
Patents as Topic - ethics
Patents as Topic - legislation & jurisprudence
Citation

Available from:

Online
Loading holdings.
Unable to load. Retry?
Loading holdings...
Unable to load. Retry?